Page last updated: 2024-08-17
rotenone and mdv 3100
rotenone has been researched along with mdv 3100 in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Cai, S; Cichewicz, RH; Mooberry, SL; Robles, AJ | 1 |
Other Studies
1 other study(ies) available for rotenone and mdv 3100
| Article | Year |
|---|---|
Selective activity of deguelin identifies therapeutic targets for androgen receptor-positive breast cancer.
Topics: Animals; Antineoplastic Agents; Benzamides; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cell Survival; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Humans; Mice; Nitriles; Phenylthiohydantoin; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Receptors, Androgen; Rotenone; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays | 2016 |